Literature DB >> 6753885

Kinetics of the uptake and elimination of chloroquine in children with malaria.

S A Adelusi, A H Dawodu, L A Salako.   

Abstract

1 Ten children with Plasmodium falciparum malaria were treated with 25 mg/kg chloroquine over 3 days and observed for 7 days. 2 Chloroquine was determined in the red blood cells and plasma, and the red blood cell/plasma chloroquine concentration ratio was correlated with the disappearance of the parasites from the blood. It was found that this ratio decreased with the disappearance of the parasites and remained almost steady after the parasites had disappeared completely from the blood. 3 The half-life (t1/2) and the elimination rate constant of the "terminal' elimination slope (lambda beta) of the plasma log concentration-time curve were estimated to be 135.9 +/- 9.92 h and 0.005 +/- 0.001 h-1 (s.d.) respectively. 4 The t1/2 and lambda beta calculated from the red blood cell log concentration-time curve were not significantly different from the corresponding values calculated from the plasma log concentration-time curve.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6753885      PMCID: PMC1427606          DOI: 10.1111/j.1365-2125.1982.tb02016.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Morphological effects of chloroquine on Plasmodium berghei in mice.

Authors:  P B Macomber; H Sprinz
Journal:  Nature       Date:  1967-05-27       Impact factor: 49.962

2.  Mode of action of chloroquine on Plasmodium berghei and P. cynomolgi.

Authors:  D C Warhurst; D J Hockley
Journal:  Nature       Date:  1967-05-27       Impact factor: 49.962

3.  Improved fluorimetric assay of chloroquine in biological samples.

Authors:  S A Adelusi; L A Salako
Journal:  J Pharm Pharmacol       Date:  1980-10       Impact factor: 3.765

4.  The metabolism of chloroquine in man during and after repeated oral dosage.

Authors:  E W McChesney; M J Fasco; W F Banks
Journal:  J Pharmacol Exp Ther       Date:  1967-11       Impact factor: 4.030

5.  Chloroquine: physiological basis of drug resistance in Plasmodium berghei.

Authors:  P B Macomber; R L O'Brien; F E Hahn
Journal:  Science       Date:  1966-06-03       Impact factor: 47.728

6.  Chloroquine serum concentration and side effects: evidence for dose-dependent kinetics.

Authors:  M Frisk-Holmberg; Y Bergkvist; B Domeij-Nyberg; L Hellström; F Jansson
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

7.  Chloroquine sensitivity of Plasmodium falciparum in Ibadan, Nigeria.

Authors:  A F Aderounmu; L A Salako; S A Adelusi
Journal:  Trans R Soc Trop Med Hyg       Date:  1980       Impact factor: 2.184

  7 in total
  24 in total

1.  Efficacy of a loading dose of oral chloroquine in a 36-hour treatment schedule for uncomplicated plasmodium falciparum malaria.

Authors:  E Pussard; J P Lepers; F Clavier; L Raharimalala; J Le Bras; M Frisk-Holmberg; Y Bergqvist; F Verdier
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Time-dependent variability of chloroquine secretion into human saliva.

Authors:  C O Onyeji; F A Ogunbona
Journal:  Pharm World Sci       Date:  1996-12

3.  Influence of route of administration on the pharmaco-kinetics of chloroquine and desethylchloroquine.

Authors:  L A Salako; A F Aderounmu; O Walker
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

Review 4.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

5.  Chloroquine in malaria. Isn't it time for revision of prophylaxis schedules?

Authors:  M Frisk; G Gunnert
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Comparison of the pharmacokinetics of chloroquine after single intravenous and intramuscular administration in healthy Africans.

Authors:  A F Aderounmu; L A Salako; B Lindström; O Walker; L Ekman
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

7.  Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen.

Authors:  Celestino Obua; Urban Hellgren; Muhammed Ntale; Lars L Gustafsson; Jasper W Ogwal-Okeng; Toufigh Gordi; Markus Jerling
Journal:  Br J Clin Pharmacol       Date:  2008-02-20       Impact factor: 4.335

8.  Cardiovascular toxicity and distribution kinetics of intravenous chloroquine.

Authors:  S Looareesuwan; N J White; P Chanthavanich; G Edwards; D D Nicholl; C Bunch; D A Warrell
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

9.  Inoculum effect with chloroquine and Plasmodium falciparum.

Authors:  I Y Gluzman; P H Schlesinger; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

Review 10.  Clinical pharmacokinetics of drugs used in juvenile arthritis.

Authors:  K J Skeith; F Jamali
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.